does injection site matter for semaglutide Sites: Abdomen vs. Thigh – Which Is Better? Where to inject for MAXIMUM

For semaglutide, the earliest realistic timeline for generic injectable entry: 2029: Generic manufacturers begin bioequivalence studies (2 years before the 2031 method-of-use patent expiration) 2030: ANDA submissions filed 2031-2032: FDA approvals granted, market entry Generic oral semaglutide could follow a faster timeline because Teva's Paragraph IV strategy (using a different absorption enhancer) avoids the SNAC patent entirely: 2026: Teva completes bioequivalence studies (already done as of April 2026) 2026: ANDA submission 2027: FDA approval, market entry The gap between patent expiration and market entry is why patients should not expect immediate cost relief when patents expire

Despite the website advertising 48-hour delivery, mine arrived overnight

doi:10.3390/nu10121971 134

Buyer Takeaway: FeelGood's value proposition is real: clinician-supervised access to compounded GLP-1 through a platform designed around digital convenience, without insurance requirements or office visits

DSIP uses different pathways in the central nervous system

The CARS is a 15-item clinician-rated behavioural scale that integrates caregiver reports with direct clinical observation